Fumonisin B2
Fumonisin B2 is a mycotoxin produced by certain species of Fusarium fungi, notably Fusarium verticillioides and Fusarium proliferatum. These fungi are commonly found on maize (corn) and other cereals, where they can infect crops in the field or during storage. Fumonisin B2, along with its more studied counterpart, Fumonisin B1, is associated with various animal and potentially human health risks, highlighting the importance of monitoring and managing fumonisin levels in food and feed products.
Health Effects[edit | edit source]
Fumonisin B2 has been studied to a lesser extent than Fumonisin B1, but it is known to exhibit toxicity in animals and potentially in humans. In animals, exposure to fumonisins has been linked to diseases such as leukoencephalomalacia in horses, pulmonary edema in pigs, and liver and kidney damage in other species. The implications for human health are less clear, but there is concern that fumonisins may contribute to cancer, especially esophageal cancer, and birth defects. The International Agency for Research on Cancer (IARC) has classified fumonisins as "possibly carcinogenic to humans" (Group 2B).
Detection and Control[edit | edit source]
Efforts to detect and control fumonisins in the food supply involve a combination of agricultural practices, such as crop rotation and the use of resistant maize varieties, and post-harvest interventions, including proper drying and storage of cereals. Analytical methods for detecting fumonisin B2 and other fumonisins include liquid chromatography coupled with mass spectrometry (LC-MS) and enzyme-linked immunosorbent assay (ELISA).
Regulation[edit | edit source]
Various countries and international bodies have established guidelines or regulations for acceptable levels of fumonisins in food and feed. These regulations are based on scientific assessments of the risks posed by fumonisins to animal and human health and are intended to minimize exposure to these toxins.
Conclusion[edit | edit source]
While fumonisin B2 is less studied than Fumonisin B1, it is a significant concern due to its presence in widely consumed foods and its potential health risks. Ongoing research and monitoring are essential to better understand the impacts of fumonisin B2 and to develop effective strategies for minimizing exposure to this and other mycotoxins.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD